Edgewise Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021
Market Capitalization	1,600	694	565	753
Market Cap Growth	-	22.85%	-24.97%	-
Enterprise Value	1,072	381	218	472
PE Ratio	-16.05	-6.93	-8.35	-17.59
PB Ratio	2.99	2.18	1.63	2.75
P/FCF Ratio	-17.09	-7.11	-9.71	-22.04
P/OCF Ratio	-17.38	-7.55	-10.74	-22.48
EV/EBITDA Ratio	-11.28	-3.87	-3.24	-11.11
EV/EBIT Ratio	-11.06	-3.81	-3.22	-11.04
EV/FCF Ratio	-11.78	-3.90	-3.74	-13.82
Debt / Equity Ratio	0.01	0.02	0.01	-
Debt / EBITDA Ratio	-0.05	-0.06	-0.07	-
Debt / FCF Ratio	-0.05	-0.06	-0.08	-
Quick Ratio	36.49	18.98	21.22	26.69
Current Ratio	37.08	19.50	21.53	26.97
Return on Equity (ROE)	-29.10%	-32.10%	-22.30%	-14.70%
Return on Assets (ROA)	-27.60%	-30.20%	-21.20%	-14.30%
Return on Capital (ROIC)	-22.84%	-35.27%	-20.41%	-15.75%
Earnings Yield	-6.62%	-14.43%	-11.97%	-5.68%
FCF Yield	-6.21%	-14.07%	-10.30%	-4.54%
Buyback Yield / Dilution	-38.41%	-18.90%	-42.82%	-4977.96%
Total Shareholder Return	-38.41%	-18.90%	-42.82%	-4977.96%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).